New Hampshire HB 705: relative to sexual assault, sexual misconduct in institutions of higher education, and the rights of victims of crime.
Status: Signed by Governor Sununu 07/20/2020; Chapter 24; I. Sec. 1-7 & 9-16 Eff: 09/18/2020 II. Sec 18 Eff: 01/16/2021 III. Rem Eff: 7/20/2020 (as of 2020-07-22)
State: New Hampshire · Session: 2020 · Bill: HB 705
Bill Text
HB 705 - VERSION ADOPTED BY BOTH BODIES 26Mar2025... 1090h 8Jan2026... 0126EBA 2025 SESSION 25-0576 05/08 HOUSE BILL 705 AN ACT relative to health care cost transparency. SPONSORS: Rep. Ammon, Hills. 42; Rep. Burroughs, Carr. 2; Rep. Hunt, Ches. 14; Rep. Soti, Rock. 35 COMMITTEE: Commerce and Consumer Affairs ───────────────────────────────────────────────────────────────── AMENDED ANALYSIS This bill requires health plans to disclose specific pricing information regarding covered items and services. The bill is contingent upon finalization of federal guidance under Presidential Executive Order 14221. - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Explanation: Matter added to current law appears in bold italics. Matter removed from current law appears [in brackets and struckthrough.] Matter which is either (a) all new or (b) repealed and reenacted appears in regular type. 26Mar2025... 1090h 8Jan2026... 0126EBA 25-0576 05/08 STATE OF NEW HAMPSHIRE In the Year of Our Lord Two Thousand Twenty Five AN ACT relative to health care cost transparency. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Subdivision; Managed Care Law; Transparency in Coverage. Amend RSA 420-J by inserting after section 26 the following new subdivision: Transparency in Coverage 420-J:27 Definitions. In this subdivision: I. “Billed charge” means the total charges for an item or service billed to a health carrier by a provider. II. “Billing code” means the code used by a health carrier or provider to identify health care items or services for purposes of billing, adjudicating, and paying claims for a covered item or service, including the current procedural terminology (CPT) code, health care common procedure coding system (HCPCS) code, diagnosis-related group (DRG) code, national drug code (NDC), or other common payer identifier. III. “Bundled payment arrangement” means a payment model under which a provider is paid a single payment for all covered items and services provided to a covered person for a specific treatment or procedure. IV. “Derived amount” means the price that a health carrier assigns to an item or service for the purpose of internal accounting, reconciliation with providers or submitting data in accordance with state or federal regulations. V. “Health plan” means health carriers, third party administrators, and any other entity that is subject to claims data submission requirements under RSA 420-G:11 IV. VI. “Historical net price” means the retrospective average amount a health carrier paid for a prescription drug, inclusive of any reasonably allocated rebates, discounts, chargebacks, fees, and any additional price concessions received by the carrier with respect to the prescription drug. The allocation shall be determined by dollar value for nonproduct-specific and product-specific rebates, discounts, chargebacks, fees, and other price concessions to the extent that the total amount of any such price concession is known to the health carrier at the time of publication of the historical net price in a machine-readable file in accordance with this subdivision. However, to the extent that the total amount of any nonproduct-specific and product-specific rebates, discounts, chargebacks, fees, or other price concessions is not known to the health carrier at the time of file publication, then the carrier shall allocate such rebates, discounts, chargebacks, fees, and other price concessions by using a good faith, reasonable estimate of the average price concessions based on the rebates, discounts, chargebacks, fees, and other price concessions received over a time period prior to the current reporting period and of equal duration to the current reporting period. VII. “Items or services” means all encounters, procedures, medical tests, supplies, prescription drugs, durable medical equipment, and fees, including facility fees, provided or assessed in connection with the provision of health care. VIII. “Machine-readable file” means a digital representation of data or information in a file that can be imported or read by a computer system for further processing without human intervention, while ensuring no semantic meaning is lost. IX. “National drug code” means the unique 10- or 11-digit 3-segment number assigned by the United States Food and Drug Administration (FDA), which provides a universal product identifier for drugs in the United States. X. “Negotiated rate” means the amount a health carrier has contractually agreed to pay an in-network provider, including an in-network pharmacy or other prescription drug dispenser, for covered items and services, whether directly or indirectly, including through a third-party ad
View New Hampshire HB 705 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.